This is an editorial summary of research originally reported by The Lancet. ProductSafer does not claim ownership of the underlying research. All intellectual property belongs to the original publishers.
Free weekly digest
We track health and safety research on food, cosmetics, and household products and send you what matters. Join 27 readers.
What would you like to do next?
I use this product
Get the next safety alert before it goes viral
Free weekly digest of health findings about everyday products. No spam, unsubscribe any time.
Advertisement
Get the latest health findings delivered to your inbox. Only the important stuff. No spam.
We'll send a confirmation email. Unsubscribe anytime.
Finerenone, a drug already used for type 2 diabetes, now shows it can protect kidneys in people with chronic kidney disease who don't have diabetes. This matters because kidney disease kills someone every 20 seconds worldwide, and most patients with non-diabetic kidney disease have limited treatment options. The finding expands who can benefit from this drug and offers new hope for millions of people at risk.
Finerenone, a medication currently prescribed for type 2 diabetes, has demonstrated new protective benefits for kidney disease patients without diabetes. Researchers found that the drug slows the decline of kidney function in people with chronic kidney disease who don't have diabetes. This discovery matters because chronic kidney disease affects millions worldwide, and treatment options for non-diabetic patients have been limited.
Chronic kidney disease is a serious global health issue. Someone dies from kidney-related complications every 20 seconds around the world. Most people with non-diabetic forms of the disease have few medications available to slow its progression. The research showing finerenone's protective effects opens up a new treatment path for these patients.
The study expands the potential use of finerenone beyond its current diabetes application. The drug works to protect kidney tissue and reduce the rate at which kidney function deteriorates. For patients with non-diabetic chronic kidney disease, this could mean slowing the progression toward kidney failure and dialysis.
If you have chronic kidney disease without diabetes, talk to your doctor about whether finerenone might be right for you. This research suggests the drug could help protect your kidneys, but it's not suitable for everyone. Your healthcare provider can assess your specific situation and discuss whether this treatment fits your needs.
Always consult a healthcare professional for personal medical advice.
Read the full report at the original source
The LancetWas this finding useful?
Community discussion
Join the discussion
Comments are reviewed before appearing publicly.